BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7855108)

  • 21. Amyloid goiter in a case of systemic amyloidosis secondary to ankylosing spondylitis.
    Cohan P; Hirschowitz S; Rao JY; Tanavoli S; Van Herle AJ
    J Endocrinol Invest; 2000 Dec; 23(11):762-4. PubMed ID: 11194711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal amyloidosis. Histological differentiation based on chemical types compared to Reimann's classification.
    Kemény E; Mohácsi G; Sonkodi S; Ormos J
    Zentralbl Allg Pathol; 1983; 128(5-6):379-89. PubMed ID: 6677007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AA Amyloidosis and IgG4-Related Disease.
    Karim F; Clahsen-van Groningen M; van Laar JA
    N Engl J Med; 2017 Feb; 376(6):599-600. PubMed ID: 28177871
    [No Abstract]   [Full Text] [Related]  

  • 24. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
    Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
    Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Giant cell arteritis "causing" AA-amyloidosis with rapid renal failure.
    Strasser F; Hailemariam S; Weinreich T; Speich R; Salomon F
    Schweiz Med Wochenschr; 2000 Oct; 130(43):1606-9. PubMed ID: 11100514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical-pathologic differentiation of common amyloid syndromes.
    Wright JR; Calkins E
    Medicine (Baltimore); 1981 Nov; 60(6):429-48. PubMed ID: 7031413
    [No Abstract]   [Full Text] [Related]  

  • 27. Localized pleural microdeposition of type A amyloid in a patient with rheumatoid pleuritis. Histologic distinction from pleural involvement in systemic amyloidosis.
    Smith FB; Brown RB; Maguire G; Oliver J
    Am J Clin Pathol; 1993 Mar; 99(3):261-4. PubMed ID: 8447287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid goiter: the first evidence in secondary amyloidosis. Report of five cases and review of literature.
    D'Antonio A; Franco R; Sparano L; Terzi G; Pettinato G
    Adv Clin Path; 2000 Apr; 4(2):99-106. PubMed ID: 11082224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A patient with psoriatic arthritis and secondary amyloidosis].
    Atanasova P; Dimitrova D; Milkov V
    Vutr Boles; 1989; 28(6):79-82. PubMed ID: 2633485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic, secondary amyloidosis in a patient with psoriatic arthritis.
    Ujfalussy I; Bély M; Koó E; Seszták M
    Clin Exp Rheumatol; 2001; 19(2):225. PubMed ID: 11326492
    [No Abstract]   [Full Text] [Related]  

  • 31. Amyloidosis complicating hairy cell leukemia.
    Linder J; Silberman HR; Croker BP
    Am J Clin Pathol; 1982 Dec; 78(6):864-7. PubMed ID: 7148752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid goiter: report of two cases and review of the literature.
    Goldsmith JD; Lai ML; Daniele GM; Tomaszewski JE; LiVolsi VA
    Endocr Pract; 2000; 6(4):318-23. PubMed ID: 11242609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The possible pathogenesis of AA type amyloidosis in a patient with ulcerative colitis and renal cell carcinoma].
    Kostadinova-Kunovska S; Petrusevska G; Grcevska L; Banev S; Dzikova S; Bogoeva B; Polenaković M
    Acta Med Croatica; 2006 Jun; 60(3):251-4. PubMed ID: 16933838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Amyloid goiter: first sign of systemic amyloidosis].
    Chraibi A; Msyah L; Laaribi O; Marrakchi A; Hafidi A
    Ann Endocrinol (Paris); 2009 Mar; 70(1):80-2. PubMed ID: 18082156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversal of nephrotic syndrome due to AA amyloidosis in psoriatic patients on long-term colchicine treatment. Case report and review of the literature.
    Kagan A; Husza'r M; Frumkin A; Rapoport J
    Nephron; 1999; 82(4):348-53. PubMed ID: 10450037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral involvement in a case of AA amyloidosis.
    Koloktronis A; Chatzigiannis I; Paloukidou N
    Oral Dis; 2003 Sep; 9(5):269-72. PubMed ID: 14628895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histomorphological variations in systemic AA amyloidosis: clues of AA protein polymorphism.
    Looi LM
    Histopathology; 1989 Feb; 14(2):111-20. PubMed ID: 2707747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathological and clinical correlations in renal AA amyloidosis: A Moroccan series of 30 cases].
    Bziz A; Rouas L; Lamalmi N; Malihy A; Cherradi N; Ouzeddoun N; Bayahia R; Flayou K; Chala S; Bouclouze A; Benomar A; Abouqal R; Alhamany Z
    Nephrol Ther; 2015 Dec; 11(7):543-50. PubMed ID: 26608566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal disease and goitre: a new syndrome of primary amyloidosis.
    Cooke RA; Champness LT
    Aust Paediatr J; 1972 Oct; 8(5):250-4. PubMed ID: 4658963
    [No Abstract]   [Full Text] [Related]  

  • 40. Massive systemic amyloidosis associated with light-chain deposition disease.
    Troussard X; Hurault de Ligny B; Gallet B; Ganeval D; Mandard JC; Ryckelynck JP; Leporrier M
    Nephron; 1989; 52(2):139-43. PubMed ID: 2500613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.